Table 1.
March and April 2019 | March and April 2020 | p-value | |
---|---|---|---|
Patients | 55 | 49 | |
Weekly STEMI patients | 6.9±1.9 | 6.1±2.4 | 0.494 |
Age, years | 61.9±12 | 64.5±13.8 | 0.308 |
Male gender | 46 (84.8%) | 38 (77.6%) | 0.295 |
Hypertension | 35 (63.6%) | 38 (77.6%) | 0.091 |
Type 2 diabetes | 16 (29.1%) | 11 (22.4%) | 0.293 |
Dyslipidemia | 29 (52.7%) | 32 (65.3%) | 0.135 |
Clinical HF | 3 (5.5%) | 1 (2%) | 0.354 |
Chronic kidney disease | 4 (7.3%) | 2 (4.1%) | 0.396 |
Previous stroke | 2 (3.6%) | 3 (6.1%) | 0.445 |
Current smoker | 24 (43.6%) | 18 (36.7%) | 0.303 |
Creatinine, mg/dL | 1.1±0.7 | 1.1±0.5 | 0.769 |
Previous peripheral arterial disease | 2 (3.6%) | 1 (2%) | 0.721 |
Previous myocardial Infarction | 1 (1.8%) | 1 (2%) | 0.872 |
Previous PCI | 1 (1.8%) | 1 (2%) | 0.872 |
Previous CABG | 0 | 0 | |
Pre-hospital emergency medical service | 21 (38.2%) | 10 (20.4%) | 0.038 |
Patient delay, min | 240 [120-570] | 360 [120-600] | 0.940 |
System delay, min | 49 [30-110.25] | 140 [90-180] | 0.019 |
Killip-Kimball class | 1.4±0.8 | 1.9±1.2 | 0.006 |
I | 41 (74.5%) | 25 (51%) | |
II | 10 (18.2%) | 11 (22.4%) | |
III | 1 (1.8%) | 4 (8.2%) | |
IV | 3 (5.5%) | 9 (18.4%) |
CABG: coronary artery bypass graft; HF: heart failure; PCI: percutaneous coronary intervention; STEMI: ST-elevation myocardial infarction.